Clinical Trials

Phase 3 Active not recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06635824 2026-03-12

Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06)

191 enrolled

Lung Neoplasms

NCT06881784 2026-03-12

RASolve 301

Phase 3 Recruiting

420 enrolled

Phase 3 Active not recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05450692 2025-11-19

LATIFY

594 enrolled

Phase 1 Active not recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00600496 2025-11-13

A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)

140 enrolled

BreastDermatologicGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Colonic Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasms

NCT04794699 2025-11-12

Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion

Phase 1 Recruiting

180 enrolled

GenitourinaryThoracic

Urinary Bladder Neoplasms, Lung Neoplasms

NCT05132075 2025-11-10

KontRASt-02

Phase 3 Active not recruiting

95 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06228326 2025-10-24

KYANITE-1

Phase 1/2 Recruiting

250 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT00532155 2025-09-10

VITAL

913 enrolled 16 charts

Carcinoma, Lung Neoplasms

NCT04364620 2025-04-06

AB-16B5 Combined With Docetaxel in Subjects With Metastatic Non-Small Cell Lung Cancer (EGIA-002)

35 enrolled 17 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01828112 2025-02-07

LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib

231 enrolled 33 charts

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04863248 2023-04-14

PRESERVE 4

10 enrolled 14 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

NCT00103389 2022-06-27

Docetaxel With or Without PI-88 in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

98 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01207011 2022-04-12

Amrubicin (AMR) Trial in Patients With Non-small Cell Lung Cancer

202 enrolled

Lung Neoplasms

NCT01168973 2019-09-25

A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based Chemotherapy

1,253 enrolled 18 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01646125 2019-07-24

An Open-label, Randomized Phase II Study to Evaluate the Efficacy of AUY922 vs Pemetrexed or Docetaxel in NSCLC Patients With EGFR Mutations

59 enrolled 9 charts

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00086268 2017-09-13

ZPACT

250 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01138163 2017-04-19

Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer

121 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00312377 2016-09-30

ZODIAC

1,690 enrolled 15 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00405951 2016-07-21

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)in Combination With Docetaxel for the Treatment of Non-Small Cell Lung Cancer

Phase 1/2 Completed

47 enrolled

Lung Neoplasms

NCT01630733 2016-07-01

A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer

Phase 3 Unknown

700 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

NCT00766246 2016-04-19

Phase II Avastin Trial for Stage IIIB/IV NSCLC

125 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01348126 2015-11-05

GALAXY

Phase 2/3 Terminated

385 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01038752 2015-05-21

Evaluation of Non-cytotoxic Suramin as a Chemosensitizer in Non-small Cell Lung Cancer

14 enrolled 10 charts

BreastGastrointestinalGenitourinaryGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00539968 2015-02-05

A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED)

Phase 1/2 Terminated

5 enrolled

Breast Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms

NCT00511576 2015-01-08

Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors

Phase 1 Terminated

54 enrolled

BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Prostatic Neoplasms, Stomach Neoplasms

NCT01362400 2014-05-19

A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer

226 enrolled

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Carcinoma, Large Cell

NCT01038661 2014-02-28

TFINE

375 enrolled

GenitourinaryOther solid neoplasmThoracic

Lung Neoplasms

NCT01604863 2012-11-01

A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies

Phase 1 Suspended

54 enrolled

Lung Neoplasms, Mesothelioma, Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

NCT00354562 2011-01-07

A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung Cancer

Phase 1/2 Terminated

75 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00826852 2010-07-27

Weekly Docetaxel and Four Weekly Carboplatin in Non-small Cell Lung Cancer Carbo-Tax

49 enrolled

Lung Neoplasms

NCT00174772 2010-02-17

Pulmonart: Docetaxel - Non-Small Cell Lung Cancer (NSCLC)

72 enrolled

Lung Neoplasms

NCT00174629 2009-12-07

GILT Docetaxel - Non-Small Cell Lung Cancer

449 enrolled

Lung Neoplasms

NCT00258739 2009-12-07

Docetaxel in Non Small Cell Lung Cancer (NSCLC)

140 enrolled

Lung Neoplasms

NCT00070629 2009-02-10

CPG 7909 Injection in Non-Small Cell Lung Cancer

116 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00712504 2008-11-11

Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer

Phase 1 Completed

49 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00080080 2007-06-08

Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung Cancer

Lung Neoplasms

NCT00243204 2007-06-08

Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Phase 3 Terminated

400 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00066885 2007-05-07

Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer

Phase 1/2 Completed

80 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00073385 2005-08-30

Comparative Trial of Pivanex and Docetaxel Vs Docetaxel Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer

225 enrolled